Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/25/2017 |
| Start Date: | December 2008 |
| End Date: | December 2013 |
Objective of the study is to create and validate Chronic Quality of Life (CQOL) index that
explores habits, career paths and other life choices psoriasis patients make as a result of
coping with their disease that may not be impacted by therapy implemented at a given point
in time.
- The investigators think this data will show that patients who were diagnosed at a young
age will have worse chronic quality of life.
explores habits, career paths and other life choices psoriasis patients make as a result of
coping with their disease that may not be impacted by therapy implemented at a given point
in time.
- The investigators think this data will show that patients who were diagnosed at a young
age will have worse chronic quality of life.
As a visible disease, psoriasis can be embarrassing and psychosocially stressful in addition
to physically uncomfortable. Patients' lives are affected in physical, psychological,
social, sexual and occupational aspects. These burdens may cause patients to assume
maladaptive habits and coping mechanisms, leading to a downward spiral in functioning within
society, prohibiting patients from achieving their highest potential quality of life.
The investigators' study goal is to create and validate Chronic Quality of Life (CQOL) index
that explores habits, career paths and other life choices psoriasis patients make as a
result of coping with their disease that may not be impacted by therapy implemented at a
given point in time. In creating this questionnaire and validating it the investigators will
collect preliminary data. The investigators think this data will show that patients who were
diagnosed at a young age will have worse chronic quality of life. In the long run, the
investigators will use the CQOL index in studies in which patients are treated for psoriasis
to determine which treatments can change a psoriasis patient's chronic quality of life. This
information will be used to create guidelines for treatment focused on achieving a patient's
optimal quality of life.
Another aspect that the investigators would like to look at is the skin carotenoid levels in
the psoriasis population. Previous studies showed that psoriasis patients had lower levels
of skin carotenoids when compared to healthy volunteers. This observation was not
statistically significant perhaps due to a small sample size (21 subjects in the psoriasis
group and 35 subjects in the control group). Skin carotenoid levels measurement is optional
for study subjects.
to physically uncomfortable. Patients' lives are affected in physical, psychological,
social, sexual and occupational aspects. These burdens may cause patients to assume
maladaptive habits and coping mechanisms, leading to a downward spiral in functioning within
society, prohibiting patients from achieving their highest potential quality of life.
The investigators' study goal is to create and validate Chronic Quality of Life (CQOL) index
that explores habits, career paths and other life choices psoriasis patients make as a
result of coping with their disease that may not be impacted by therapy implemented at a
given point in time. In creating this questionnaire and validating it the investigators will
collect preliminary data. The investigators think this data will show that patients who were
diagnosed at a young age will have worse chronic quality of life. In the long run, the
investigators will use the CQOL index in studies in which patients are treated for psoriasis
to determine which treatments can change a psoriasis patient's chronic quality of life. This
information will be used to create guidelines for treatment focused on achieving a patient's
optimal quality of life.
Another aspect that the investigators would like to look at is the skin carotenoid levels in
the psoriasis population. Previous studies showed that psoriasis patients had lower levels
of skin carotenoids when compared to healthy volunteers. This observation was not
statistically significant perhaps due to a small sample size (21 subjects in the psoriasis
group and 35 subjects in the control group). Skin carotenoid levels measurement is optional
for study subjects.
Inclusion Criteria:
- Able to understand and sign informed consent
- Able to read English
- Able to comply with study procedure
- Male or female of at least 18 years of age
- Has a diagnosis of psoriasis
Exclusion Criteria:
- Has any medical condition that might interfere with ability to complete CQOL survey
We found this trial at
1
site
Click here to add this to my saved trials
